- Home
- EWCZ vs CATX Comparison
EWCZ vs CATX Comparison
Compare EWCZ & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- CATX
- Stock Information
- Founded
- EWCZ 2004
- CATX 1983
- Country
- EWCZ United States
- CATX United States
- Employees
- EWCZ N/A
- CATX N/A
- Industry
- EWCZ Package Goods/Cosmetics
- CATX Medical/Dental Instruments
- Sector
- EWCZ Consumer Discretionary
- CATX Health Care
- Exchange
- EWCZ Nasdaq
- CATX Nasdaq
- Market Cap
- EWCZ 239.2M
- CATX 239.0M
- IPO Year
- EWCZ 2021
- CATX N/A
- Fundamental
- Price
- EWCZ $4.15
- CATX $3.29
- Analyst Decision
- EWCZ Hold
- CATX Strong Buy
- Analyst Count
- EWCZ 6
- CATX 11
- Target Price
- EWCZ $5.50
- CATX $12.90
- AVG Volume (30 Days)
- EWCZ 375.3K
- CATX 727.5K
- Earning Date
- EWCZ 11-13-2025
- CATX 11-11-2025
- Dividend Yield
- EWCZ N/A
- CATX N/A
- EPS Growth
- EWCZ N/A
- CATX N/A
- EPS
- EWCZ 0.20
- CATX N/A
- Revenue
- EWCZ $212,509,000.00
- CATX $1,235,000.00
- Revenue This Year
- EWCZ N/A
- CATX N/A
- Revenue Next Year
- EWCZ $2.37
- CATX N/A
- P/E Ratio
- EWCZ $20.58
- CATX N/A
- Revenue Growth
- EWCZ N/A
- CATX N/A
- 52 Week Low
- EWCZ $2.72
- CATX $1.60
- 52 Week High
- EWCZ $8.91
- CATX $14.19
- Technical
- Relative Strength Index (RSI)
- EWCZ 46.34
- CATX 45.27
- Support Level
- EWCZ $3.83
- CATX $3.02
- Resistance Level
- EWCZ $3.96
- CATX $3.74
- Average True Range (ATR)
- EWCZ 0.19
- CATX 0.25
- MACD
- EWCZ 0.02
- CATX -0.01
- Stochastic Oscillator
- EWCZ 67.47
- CATX 32.53
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.